A Humoral Inhibitor of Sodium Transport in Uremic Serum
- 1 November 1970
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 126 (5) , 860-864
- https://doi.org/10.1001/archinte.1970.00310110130023
Abstract
A low molecular weight fraction of serum from uremic patients has been found to inhibit several different transport systems. These include the uptake of p-aminohippuric acid (PAH) by rabbit kidney cortical slices, the transepithelial transport of sodium by the isolated frog skin, and finally, sodium reabsorption by the rat kidney tubule. The following possibilities are considered: first, that the substance might be a naturally occurring humoral agent which serves in a homeostatic role to increase sodium excretion rate per nephron as the number of nephrons diminishes in advancing renal disease; and second, that in advanced renal disease, very high levels of this humoral agent could lead to inhibition of sodium transport in extrarenal organs and, thus, could contribute importantly to the symptoms and signs of the uremic state.This publication has 3 references indexed in Scilit:
- Control of sodium reabsorption.BMJ, 1969
- Studies on the control of sodium excretion in experimental uremiaJournal of Clinical Investigation, 1969
- Specificity of the Inhibitory Effect of "Uremic" Serum on p-Aminohippurate TransportExperimental Biology and Medicine, 1968